Iomedico Ag

This study is tracking 150 adults in Germany with metastatic colorectal cancer who are taking Fruquintinib as part of their normal medical care. The goal is to see how well the drug controls the disease and affects quality of life after other standard treatments have stopped work…

This study looks at how well the drug ivosidenib works for people with advanced bile duct cancer that has a specific IDH1 gene mutation. About 100 adults in Germany who have already tried at least one other cancer treatment will take ivosidenib as prescribed. Researchers will tra…

This study follows about 200 adults with polycythemia vera (a blood disorder) who do not have an enlarged spleen and are starting treatment with ropeginterferon alfa-2b. Researchers will track symptoms, blood cell counts, and side effects over 36 months in real-world clinics. The…

This study is a large registry that will follow nearly 3,000 people with blood cancers like chronic lymphocytic leukemia and several types of lymphoma. Researchers will collect information on treatments, how the disease progresses, and patients' quality of life over time. The goa…

This study follows 150 adults with IDH-mutant grade 2 glioma who are taking vorasidenib after surgery. Researchers will track quality of life, seizure control, and tumor response in everyday clinical practice. The goal is to understand how well the drug works outside of strict tr…

This study follows 705 adults with Waldenström's macroglobulinemia, chronic lymphocytic leukemia, marginal zone lymphoma, or follicular lymphoma who are taking zanubrutinib (with or without obinutuzumab) as part of their normal care. Researchers will track hospital visits, qualit…

This study is following over 6,000 breast cancer patients in Germany to see what treatments they actually receive in routine care and how they fare over time. Researchers are collecting data on treatment patterns, survival, and quality of life from patients with early and advance…

This study is a German registry that will follow about 2,000 people with advanced ovarian or endometrial cancer. Researchers will collect information on the treatments patients actually receive, how well they work, and how patients feel. The goal is to understand real-world care …

This study is a research platform that will follow about 200 people in Germany who have myelofibrosis (a type of bone marrow cancer) and anemia (low red blood cells). It will collect information on the treatments they receive, how their disease changes over time, and their qualit…

This study is a large registry that will follow 2200 people with multiple myeloma in Germany. Its goal is to collect information on the types of treatments patients actually receive, how well they work, and how patients feel over time. Participants will provide medical data and o…

This study is a large registry that follows about 1,930 people with advanced kidney or bladder cancer in Germany. Researchers will collect information on treatments, disease progression, quality of life, and tumor samples to understand how these cancers are managed in everyday pr…

This study is a large registry that will collect information from about 1,900 people with advanced cancer of the esophagus or stomach who are receiving palliative treatment in Germany. The goal is to understand what treatments are actually used in everyday practice and how patien…